Bench-to-bedside review: Cytopathic hypoxia

Critical Care

Volumn 6, Issue 6, 2002, Pages 491-499

  Fink, Mitchell P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; CELL ACTIVITY; CELL HYPOXIA; CELL RESPIRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENERGY YIELD; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MICROVASCULARIZATION; MITOCHONDRION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW; SEPSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL RESPIRATION; HUMANS; LIPOPOLYSACCHARIDES; MITOCHONDRIAL DISEASES; NAD; OXIDATIVE PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; SEPSIS;

EID: 0036892452     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1824     Document Type: Review

References (67)

1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
2. Tuchschmidt J, Fried J, Astiz M, Rackow E: Elevation of cardiac output and oxygen improves outcome in septic shock. Chest 1992, 102:216-220.
3. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995, 333:1025-1032.
4. Hayes MA, Timmins AC, Yau EHS, Palazzo M, Hinds CJ, Watson D: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717-1722.
5. Hotchkiss RS, Karl IE: Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992, 267: 1503-1509.
6. Fink MP: Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand 1997, 41 (suppl 100):87-95.
7. Fink MP: Cytopathic hypoxia: mitochondrial dysfunction as a mechanism contributing to organ dysfunction in sepsis. Crit Care Clin North Am 2001, 17:219-237.
8. Barcroft J: On anoxaemia. Lancet 1920, ii:485.
9. Astiz M, Rackow EC, Weil MH, Schumer W: Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock 1988, 26:311-320.
10. 18F]fluoroisonidazole. Am J Physiol 1991, 261:R965-R972.
11. VanderMeer TJ, Wang H, Fink MP: Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 1995, 23:1217-1226.
12. Rosser DM, Stidwill RP, Jacobson D, Singer M: Oxygen tension in the bladder epithelium rises in both high and low cardiac output endotoxemic sepsis. J Appl Physiol 1995, 79:1878-1882.
13. Boekstegers P, Weidenhofer S, Pilz G, Werdan K: Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock. Infection 1991, 19:317-323.
14. Sair M, Etherington PJ, Winlove CP, Evans TW: Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med 2001, 29:1343-1349.
15. Simonson SG, Welty-Wolf K, Huang Y-CT, Griebel JA, Caplan MS, Fracica PJ, Piantadosi CA: Altered mitochondrial redox responses in Gram negative septic shock in primates. Circ Shock 1994, 43:34-43.
16. 2 in endotoxemic dogs during shock and resuscitation. J Appl Physiol 1994, 76:793-800.
17. Hasibeder W, Germann R, Wolf HJ, Haisjackl M, Hausdorfer H, Riedmann B, Bonatti J, Gruber E, Schwarz B, Waldenberger P, Friesenecker B, Furtner B: Effects of short-term endotoxemia and dopamine on mucosal oxygenation in porcine jejunum. Am J Physiol 1996, 270:G667-G675.
18. Sair M, Etherington PJ, Curzen NP, Winlove CP, Evans TW: Tissue oxygenation and perfusion in endotoxemia. Am J Physiol 1996, 271:H1620-H1625.
19. Bankey PE, Hill S, Geldon D: Sequential insult enhances liver macrophage-signaled hepatocyte dysfunction. J Surg Res 1994, 57:185-191.
20. Zingarelli B, Day BJ, Crapo JD, Salzman AL, Szabó C: The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997, 120:259-267.
21. Unno N, Wang H, Menconi MJ, Tytgat SHAJ, Larkin V, Smith M, Morin MJ, Chavez A, Hodin RA, Fink MP: Inhibition of inducible nitric oxide synthase ameliorates lipopolysaccharide-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997, 113:1246-1257.
22. Gross SS, Levi R: Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 1992, 267:25722-25729.
23. Kantrow SP, Taylor DE, Carraway MS, Piantadosi CA: Oxidative metabolism in rat hepatocytes and mitochondria during sepsis. Arch Biochem Biophys 1997, 345:278-288.
24. King CJ, Tytgat S, Delude RL, Fink MP: Ileal mucosal oxygen consumption is decreased in endotoxemic rats but is restored toward normal by treatment with aminoguanidine. Crit Care Med 1999, 27:2518-2524.
25. Vary TC, Siegel JH, Nakatani T, Sato T, Aoyama H: Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 1986, 250:E634-E640.
26. Vary TC: Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate. Shock 1996, 6:89-94.
27. Vary TC, Hazen S: Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem 1999, 198:113-118.
28. Vary TC: Increased pyruvate dehydrogenase kinase activity in response to sepsis. Am J Physiol 1991, 250:E669-E674.
29. Borutaité V, Brown GC: Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem J 1996, 315:295-299.
30. Cassina A, Radi R: Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996, 328:309-316.
31. Takehara Y, Kanno T, Yoshioka T, Inoue M, Utsumi K: Oxygen-dependent regulation of mitochondrial energy metabolism by nitric oxide. Arch Biochem Biophys 1995, 323:27-32.
32. Nishikawa M, Sato EF, Kuroki T, Inoue M: Role of glutathione and nitric oxide in the energy metabolism of rat liver mitochondria. Febs Lett 1997, 415:341-345.
33. Torres J, Darley-Usmer V, Wilson MT: Inhibition of cytochrome c oxidase in turnover by nitric oxide: mechanism and implications for control of respiration. Biochem J 1995, 312:169-173.
34. Giuffre A, Sarti P, D'Itri E, Buse G, Soulimane T, Brunori M: On the mechanism of inhibition of cytochrome c oxidase by nitric oxide. J Biol Chem 2000, 271:33404-33408.
35. Brown GC, Bolanos JP, Heales SJ, Clark JB: Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci Lett 1995, 193:201-204.
36. Wink DA, Mitchell JB: Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998, 25:434-456.
37. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995, 268:L699-L722.
38. Squadrito GL, Pryor WA: Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 2001, 25:392-403.
39. Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A: Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001, 30:463-488.
40. Du G, Mouithys-Mickalad A, Sluse FE: Generation of superoxide anion by mitochondria and impairment of their functions during anoxia and reoxygenation in vitro. Free Radic Biol Med 1988, 25:1066-1074.
41. Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, Boveris A: Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 1996, 328: 85-92.
42. Ghafourifar P, Richter C: Nitric oxide synthase activity in mitochondria. FEBS Lett 1997, 418:291-296.
43. Kanai AJ, Pearce LL, Clemens PR, Birder LA, VanBibber MM, Choi SY, de Groat WC, Peterson J: Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci USA 2001, 98: 14126-14131.
44. Ghafourifar P, Schenk U, Klein SD, Richter C: Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J Biol Chem 1999, 27: 31185-31188.
45. Lacza Z, Puskar M, Figueroa JP, Zhang J, Rajapakse N, Busija DW: Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic Biol Med 2001, 31:1609-1615.
46. Packer MA, Porteous CM, Murphy MP: Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem Mol Biol Int 1996, 40:527-534.
47. Radi R, Rodriguez M, Castro L, Telleri R: Inhibition of mitochondrial electron transport by peroxynitrite. Arch Bioch Biophys 1994, 308:96-102.
48. Brealey, D, Brand M, Hargreaves I, Heales S, Land S, Smolenski R, Davies NA, Cooper CE, Singer M. Association between mitochondiral dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
49. Castro L, Rodriguez M, Radi R: Aconitase is readily inactivated by peroxynitrite, but not its precursor, nitric oxide. J Biol Chem 1994, 269:29409-29415.
50. Boczkowski J, Lisdero C, Lanone S, Samb A, Carreras MC, Boveris A, Aubier M, Poderoso JJ: Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J 1999, 13:1637-1646.
51. Durkacz BW, Omidiji O, Gray DA, Shall S: (ADP-ribose)n participates in DNA excision repair. Nature 1980, 283:593-596.
52. Saitoh MS, Poirier GG, Lindahl T: Dual function for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry 1994, 33:7099-7106.
53. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares H, Smulson ME: Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication. Mol Cell Biochem 1999, 193:137-148.
54. Lautier D, Lageux J, Thibodeau J, Ménard L, Poirier GG: Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem 1993, 122:171-193.
55. D'Amours D, Desnoyers S, D'Silva I, Poirier GG: Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999, 342:249-268.
56. Ame JC, Jacobson EL, Jacobson MK: Molecular heterogeneity and regulation of poly(ADP-ribose) glycohydrolase. Mol Cell Biochem 1999, 193:75-81.
57. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG: Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest 1986, 77:1312-1320.
58. Szabó C, Zingarelli B, O'Connor M, Salzman AL: DNA strand breakage, activation of poly-ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 1996, 93:1753-1758.
59. Zingarelli B, O'Connor M, Wong H, Salzman AL, Szabó C: Peroxynitrite-mediated DNA strand breakage activates poly-ADP ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 1996, 156:350-358.
60. Szabó C, Zingarelli B, Salzman AL: Role of poly-ADP ribosyl-transferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 1996, 78:1051-1063.
61. 2 consumption by immunostimulated Caco-2 cells. Am J Physiol 2002, 282:L1082-L1091.
62. Kim H, Jacobson EL, Jacobson MK: Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolases. Science 1993, 261:1330-1333.
63. Pulido EJ, Shames BD, Selzman CH, Barton HA, Banerjee A, Bensard DD, McIntyre RC Jr: Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation. Am J Physiol 1999, 277:L769-L776.
64. Szabó A, Salzman AL, Szabó C: Poly (ADP-ribose) synthetase activation mediates pulmonary microvascular and intestinal mucosal dysfunction in endotoxin shock. Life Sci 1998, 63: 2133-2139.
65. Kuhnle S, Nicotera P, Wendel A, Leist M: Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice. Biochem Biophys Res Commun 1999, 263:433-438.
66. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet J-C, de Murcia G: Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999, 18:4446-4454.
67. Goldfarb RD, Marton A, Szabó E, Virag L, Salzman AL, Glock D, Akhter I, McCarthy R, Parrillo JE, Szabó C: Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 2002, 30:974-980.